BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38270800)

  • 1. Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy.
    Tubridy EA; Taunk NK; Ko EM
    Curr Treat Options Oncol; 2024 Mar; 25(3):330-345. PubMed ID: 38270800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
    Hathout L; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1423-1431. PubMed ID: 33677053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
    Randall ME; Filiaci V; McMeekin DS; von Gruenigen V; Huang H; Yashar CM; Mannel RS; Kim JW; Salani R; DiSilvestro PA; Burke JJ; Rutherford T; Spirtos NM; Terada K; Anderson PR; Brewster WR; Small W; Aghajanian CA; Miller DS
    J Clin Oncol; 2019 Jul; 37(21):1810-1818. PubMed ID: 30995174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
    Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
    Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline.
    Harkenrider MM; Abu-Rustum N; Albuquerque K; Bradfield L; Bradley K; Dolinar E; Doll CM; Elshaikh M; Frick MA; Gehrig PA; Han K; Hathout L; Jones E; Klopp A; Mourtada F; Suneja G; Wright AA; Yashar C; Erickson BA
    Pract Radiat Oncol; 2023; 13(1):41-65. PubMed ID: 36280107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings.
    Bestvina CM; Fleming GF
    Oncologist; 2016 Oct; 21(10):1250-1259. PubMed ID: 27412393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
    Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
    Young MR; Higgins SA; Ratner E; Yu JB; Mani S; Silasi DA; Azodi M; Rutherford T; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
    Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH
    Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Adjuvant Radiation Plus Chemotherapy on Survival Outcomes in Stage III C Endometrial Cancer According to Histology: Analysis of Data from the Surveillance, Epidemiology, and End Results Database.
    Kou J; Yan G; Xiao L; Wei N; Ren H; Xu J
    Technol Cancer Res Treat; 2023; 22():15330338231208610. PubMed ID: 37926997
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.
    Xiang M; English DP; Kidd EA
    Brachytherapy; 2021; 20(4):701-709. PubMed ID: 33781714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
    Lu SM; Chang-Halpenny C; Hwang-Graziano J
    Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
    Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
    Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.